日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Climate sensitivity is widely but unevenly spread across zoonotic diseases

气候敏感性在人畜共患病中分布广泛但不均衡。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2422851122
Trebski, Artur; Gourlay, Lewis; Gibb, Rory; Imirzian, Natalie; Redding, David W
发表日期：2025
文献求助 收藏

A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis

一项针对非肝硬化代谢功能障碍相关脂肪性肝炎的髓过氧化物酶抑制剂Mitiperstat的2a期试验

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70406
Armisen, Javier; Flor, Armando; Eriksson, John; Nelander, Karin; Bhattacharya, Chandrali S; Sunnåker, Mikael; Carter, Debra; Trebski, Monika; Gårdmark, Emma; Aurell, Malin; Whatling, Carl; Challis, Benjamin; Vespasiani-Gentilucci, Umberto
肝炎
肝硬化
代谢
发表日期：2025
文献求助 收藏

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat

严重肾功能损害对米替帕司他药代动力学、安全性和耐受性的影响

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.16205
Bhattacharya, Chandrali S; Pizzato, Patricia Ely; Heijer, Maria; Sunnåker, Mikael; Holden, Julie; Trebski, Monika; Nelander, Karin; Ali, Hodan; Genov, Diyan K; Aurell, Malin; Collén, Anna; Ericsson, Hans
发表日期：2024
文献求助 收藏

Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers

新型髓过氧化物酶抑制剂Mitiperstat在健康日本和中国志愿者中的药代动力学和耐受性研究

期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-024-01402-x
Sunnåker, Mikael; Bhattacharya, Chandrali; Nelander, Karin; Aurell, Malin; Heijer, Maria; Collén, Anna; Han, David; Holden, Julie; Trebski, Monika; Garkaviy, Pavlo; Ericsson, Hans
发表日期：2024
文献求助 收藏